SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company. It offers SOMAmers (Slow-Offrate Modified Aptamers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein; and SOMAscan that provides protein detection and equipment. The company’s SOMAmer/SOMAscan technology enables to discover protein biomarker signatures; drug discovery and development; and clinical diagnostics. Its products have applications in the diagnostics of various diseases in oncology, neurology, cardiovascular and metabolic disease, and other diseases and conditions. SomaLogic, Inc. was founded in 1999 and is headquartered in Boulder, Colorado.
|Employees (est.) (Sept 2020)||213|
SomaLogic total Funding
SomaLogic latest funding size
Time since last funding
|3 years ago|
|ProQuest Investments, Visium Healthcare Partners, iCarbonX, Quest Diagnostics, Nan Fung Life Sciences, Madryn Asset Management, Otsuka Pharmaceutical|
SomaLogic has 1.55k Twitter Followers. The number of followers has increased 0.3% month over month and increased 0.6% quarter over quarter
Tweets last 30 days
Avg. likes per Tweet
Tweets with engagement
When was SomaLogic founded?
SomaLogic was founded in 2000.
Who are SomaLogic key executives?
SomaLogic's key executives are Larry Gold, Stephen A. Williams and Charles M. Lillis.
How many employees does SomaLogic have?
SomaLogic has 213 employees.
Who are SomaLogic competitors?
Competitors of SomaLogic include Fyodor Biotechnologies, Otsuka Novel Products and Micropoint Bioscience.
Where is SomaLogic headquarters?
SomaLogic headquarters is located at 2945 Wilderness Pl, Boulder.
Where are SomaLogic offices?
SomaLogic has an office in Boulder.
How many offices does SomaLogic have?
SomaLogic has 1 office.
Receive alerts for 300+ data fields across thousands of companies